פעילות רפואית
•Pazopanib Teva is indicated in adults for the first line treatment of advanced Renal Cell Carcinoma
(RCC) and for patients who have received prior cytokine therapy for advanced disease.
•Pazopanib Teva is indicated for the treatment of adult patients with selective subtypes of advanced
Soft Tissue Sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have
progressed within 12 months after (neo) adjuvant therapy.